A Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety and Efficacy of Cerebrolysin in Patients With Acute Ischemic Stroke.

Trial Profile

A Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety and Efficacy of Cerebrolysin in Patients With Acute Ischemic Stroke.

Completed
Phase of Trial: Phase IV

Latest Information Update: 06 Jul 2011

At a glance

  • Drugs Brain extract (Primary)
  • Indications Stroke
  • Focus Therapeutic Use
  • Acronyms CASTA
  • Sponsors Ebewe
  • Most Recent Events

    • 06 Jul 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 27 Dec 2010 Planned end date changed from 1 May 2010 to 1 Feb 2011 as reported by ClinicalTrials.gov.
    • 30 Sep 2009 Actual patient number (1071) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top